March 29, 2018 | Israeli researcher Yael Zilberman-Simakov, working at the University of Waterloo in Canada, has developed a technology for heart patients that will allow them to monitor the risk of heart failure with a prick of the finger, in the same way that diabetics currently test their blood glucose levels, the Canadian Jewish News reports. The technology is a first of its kind. Patients need jab their finger, rub the blood on a special strip, and insert it into an electronic reader. The results are available within 20 minutes. A high number means elevated levels of brain natriuretic peptide (BNP), which indicates someone is at risk of heart failure. Zilberman-Simakov developed the low-cost techonlogy in 18 months. Clinical trials are expected to begin in Canada, then move on to the US, Europe, and Asia. Zilberman-Simakov hopes the kit will be available sometime next year, with a portable smartphone-sized reader available for under $100.
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors

Ashdod Port Investing In Startups As Part Of Innovation Strategy

Facebook comments